Results 321 to 330 of about 1,471,327 (421)

High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML

open access: bronze, 2010
Alix O’Meara   +10 more
openalex   +1 more source

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study

open access: yesAnnals of Neurology, EarlyView.
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro   +16 more
wiley   +1 more source

Detecting New Lesions Using a Large Language Model: Applications in Real‐World Multiple Sclerosis Datasets

open access: yesAnnals of Neurology, EarlyView.
Objective Neuroimaging is routinely utilized to identify new inflammatory activity in multiple sclerosis (MS). A large language model to classify narrative magnetic resonance imaging reports in the electronic health record (EHR) as discrete data could provide significant benefits for MS research. The objectives of the current study were to develop such
Shane Poole   +14 more
wiley   +1 more source

Genomics of primary chemoresistance and remission induction failure in pediatric and adult acute myeloid leukemia [PDF]

open access: green, 2016
Fiona C. Brown   +19 more
openalex   +1 more source

Functional Synovium‐Based 3D Models in the Context of Human Disease and Inflammation

open access: yesAdvanced NanoBiomed Research, EarlyView.
The synovium is key to joint function but is often affected by diseases like rheumatoid arthritis. Finding better treatments is challenging because current lab models do not fully mimic real tissues. New 3D technologies, like bioprinting, offer better methods to study these diseases, improve drug testing, and develop personalized treatments, bringing ...
Amelia Heslington   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy